Diagnostic antibodies and antigens for diabetes testing: C-Peptide
Diabetes mellitus is the most known chronic disorder characterized by hyperglycemia. Diabetes mellitus is classified based on the deficiency of insulin production due to β-cell destruction (type 1) and by increased insulin resistance (type 2). The increasing rate of obesity increased the difficulties to determine the type of diabetes mellitus. The classification of diabetes mellitus is important for treatment. Beside the conventional method, the detection of biomarkers such as C-peptide reflects insulin secretion from pancreatic β cells and differentiate the diabetes mellitus type. However, the detection of these marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Genemedi supplies antibodies and antigens for diabetes testing for a wide selection of choices (please see below).
|Cat No.||Antibody/Antigen Name||Expression platform||Isotypes||Bioactivity validation||Order|
|GMP-C-Peptide-Ag||Recombinant C-peptide (C-Peptide, His Tag)||E.coli||Recombinant Antigen||C-peptide (C-Peptide) Antibody Binding, Immunogen in Sandwich ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT|